NIKKEI 225
38,310.59 +108.22 (+0.28%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.28 +0.29 (+0.37%) GOLD FUTURES
2,315.40 -6.90 (-0.30%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,143.15 -966.79 (-1.93%)
Hutchison China MediTech Limited (HCM)
After hours:
- Globe Newswire
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that Dr Renu Bhatia is appointed as an Independent Non-executive Director and a member of Technical Committee of the Company with effect from May 13, 2024. Dr Bhatia, a licensed physician, has over 25 years of experience in the healthcare, finance and fintech, and regulatory sectors. She is an experienced board di
- Globe Newswire
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based on results from FRESCO-2 Phase III clinical trial — HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that its partner Takeda (TSE:4502/NYSE:TAK) received notification that the Com
- Simply Wall St.
HUTCHMED (China) (LON:HCM) shareholders are up 8.2% this past week, but still in the red over the last five years
It is a pleasure to report that the HUTCHMED (China) Limited ( LON:HCM ) is up 35% in the last quarter. But over the...
